All Outputs (3)

Triple negative breast cancer: The role of metabolic pathways (2014)
Journal Article
Dean, S. J., & Rhodes, A. (2014). Triple negative breast cancer: The role of metabolic pathways. Malaysian Journal of Pathology, 36(3), 155-162

The incidence of breast cancer in Malaysia and other Asian countries is on the increase, reflecting lifestyle changes some of which are known risk factors for the development of breast cancer. Most breast cancers are amenable to adjuvant therapies th... Read More about Triple negative breast cancer: The role of metabolic pathways.

Loss of PTEN expression is associated with IGFBP2 expression, younger age, and late stage in triple-negative breast cancer (2014)
Journal Article
Koobotse, M. O., Holly, J. M., Perks, C. M., Dean, S. J., Bhoo-Pathy, N., Looi, L. M., …Rhodes, A. (2014). Loss of PTEN expression is associated with IGFBP2 expression, younger age, and late stage in triple-negative breast cancer. American Journal of Clinical Pathology, 141(3), 323-333. https://doi.org/10.1309/AJCPR11DEAYPTUSL

© American Society for Clinical Pathology. Objectives: To investigate the association between PTEN loss and IGFBP2 expression in a series of triple-negative breast cancers and to relate this expression to basal cytokeratin expression and clinicopatho... Read More about Loss of PTEN expression is associated with IGFBP2 expression, younger age, and late stage in triple-negative breast cancer.

An investigation in to the role of fatty acid binding protein-7, insulin like growth factor binding protein-2 and phosphatase and tensin homolog in triple negative breast cancer; in vitro and in vivo (2014)
Thesis
Dean, S. J. An investigation in to the role of fatty acid binding protein-7, insulin like growth factor binding protein-2 and phosphatase and tensin homolog in triple negative breast cancer; in vitro and in vivo. (Thesis). University of the West of England. Retrieved from https://uwe-repository.worktribe.com/output/823941

Introduction Triple negative breast cancers are defined by their lack of expression of HER, oestrogen receptors and progesterone receptors. They account for around 10-24% of cases. To define a cancer by the biomarkers it does not express is unsati... Read More about An investigation in to the role of fatty acid binding protein-7, insulin like growth factor binding protein-2 and phosphatase and tensin homolog in triple negative breast cancer; in vitro and in vivo.